Guillain-Barre Syndrome (GBS) Vaccine Injury

If you developed weakness, numbness, or difficulty walking in the weeks after receiving a flu shot, you may be experiencing Guillain-Barré Syndrome, one of the most recognized vaccine injuries in the National Vaccine Injury Compensation Program. Guillain-Barré Syndrome (GBS) vaccine injury is listed on the Vaccine Injury Table specifically for the seasonal influenza vaccine. This means that, if your symptoms began within the required timeframe after your flu shot and meet other requirements, causation may be legally presumed in your favor.

At Sadaka Law, we have represented more than 450 vaccine injury clients over more than 20 years of VICP practice, and GBS claims represent a significant part of that experience. If Guillain-Barré after flu shot describes what you are facing, we are here to help you understand your options and take the next step.

We begin every case with a free consultation, and there are no upfront attorney fees to pursue a VICP claim. To get started, reach out to Sadaka Law today by phone or through our online contact form.

GBS After Vaccination: What Is Happening and What It Means for You

Guillain-Barré Syndrome (GBS) is an autoimmune condition in which your own immune system turns against your peripheral nervous system, the network of nerves that runs outside the brain and spinal cord. This system controls movement and sensation throughout your body. GBS occurs when the immune system attacks peripheral nerves, disrupting the signals your brain sends to your muscles. In some cases, symptoms develop after vaccination, and medical and scientific evidence may support a connection between the vaccine and the condition.

The experience of GBS varies from person to person, but the pattern is recognizable: weakness that often begins in the legs and moves upward, sometimes accompanied by tingling, numbness, or pain.

In mild cases of Guillain-Barré Syndrome (GBS) vaccine injury, the weakness is significant but does not progress to paralysis. In more serious cases, GBS can cause temporary paralysis of the legs, arms, and, in the most severe situations, the muscles that control breathing. Hospitalization and intensive care are not uncommon in serious GBS cases, and some people require mechanical ventilation.

As truly frightening as this condition is, especially on the most severe end of the spectrum, most people with GBS do recover. Recovery can take months and sometimes longer. Some individuals experience lingering weakness, fatigue, or sensory changes that persist for years. The road back from this serious condition is rarely quick or simple. The compensation available through the National Vaccine Injury Compensation Program (VICP) is designed to address exactly that road, encompassing the cost of medical care, your lost income, your pain, and the long-term support your recovery may require.

GBS can affect children as well as adults. While the documented association between the influenza vaccine and GBS has been studied primarily in adult populations, children who develop GBS following a covered vaccine may still have a viable VICP claim. If your child has been diagnosed with GBS after vaccination, it’s particularly important that you act quickly. You should discuss the potential case with an attorney familiar with pediatric vaccine injury claims promptly to avoid missing the filing deadline, which is not extended just because the injured person is a minor.

Subtypes of Guillain-Barré Syndrome Linked to Vaccination

Guillain-Barré Syndrome (GBS) vaccine injury presents in several recognized forms. The most common type in North America is known as acute inflammatory demyelinating polyneuropathy (AIDP). AIDP involves damage to the myelin sheath covering the peripheral nerves, causing both motor and sensory symptoms.

Other forms of GBS include acute motor axonal neuropathy (AMAN), which primarily affects motor nerves, and acute motor and sensory axonal neuropathy (AMSAN), which affects both motor and sensory nerves. Both are axonal forms of GBS rather than primarily demyelinating conditions.

A less common variant, Fisher Syndrome, presents differently. Also known as Miller Fisher Syndrome, this subtype of GBS is characterized by eye movement problems, loss of coordination, and reduced reflexes rather than the classic ascending limb weakness.

Even if your GBS presentation has been described as atypical or if you have been diagnosed with Fisher Syndrome, you may still have a strong vaccine injury claim. The Vaccine Injury Table recognizes multiple subtypes of GBS, and a free consultation can help clarify which applies to your situation.

There is one important distinction you should know when exploring your options for pursuing compensation. In the early stages, GBS can look similar to chronic inflammatory demyelinating polyneuropathy (CIDP), a chronic autoimmune condition characterized by weakness, numbness, and loss of function.

Some patients initially diagnosed with GBS are later reclassified as having CIDP as the chronic nature of their condition becomes apparent. Legally, this matters. GBS is an on-table injury for the flu vaccine, while CIDP is not.

If your diagnosis has shifted from GBS to CIDP, your legal picture is different, and your attorney needs to understand that evolution.

GBS as an On-Table Vaccine Injury for the Flu Shot

GBS is a recognized form of flu shot injury under the VICP’s Vaccine Injury Table. In fact, Guillain-Barré Syndrome is one of only a handful of non-SIRVA conditions to appear on the Table by name for the seasonal flu vaccine.

Being able to file an on-table claim is a significant legal advantage. If the first symptom or manifestation of GBS began between three and 42 days after receiving the seasonal influenza vaccine and the condition meets the Table’s other requirements, causation may be legally presumed in your favor. You do not need to independently prove that the flu shot caused your GBS. Instead, the government may seek to establish that the condition resulted from a factor unrelated to the vaccine.

An on-table Guillain-Barré after flu shot claim is one of the most direct paths to compensation in the entire program.

To qualify for an on-table claim, your case must meet certain conditions. For example, the Table specifies that the progression of GBS from the first symptom to the point of worst weakness must occur within a window of 12 hours to 28 days. This is a separate measurement from the vaccine-to-onset window.

What this requirement means practically is that your condition must follow the recognized pattern of GBS: symptoms appear, worsen to a peak, and then plateau or begin to improve. A condition that fluctuates significantly after that initial progression, or that continues to worsen over a longer period, may suggest a different diagnosis, such as CIDP rather than GBS.

GBS following other covered vaccine types, such as meningococcal vaccines, tetanus-containing vaccines like DTaP and Tdap vaccines, and others, may also support a VICP claim. However, those cases are pursued as off-table matters, which means that they require causation evidence. The on-table advantage applies specifically to the seasonal flu vaccine.

Filing a Guillain-Barré Syndrome (GBS) Vaccine Injury Claim: What the Process Looks Like

A GBS vaccine injury claim involves the same general process as filing a VICP claim pertaining to other vaccine injuries, but there are specific documentation and timing considerations that matter for this condition.

Medical Records and Diagnostic Documentation

A GBS diagnosis is typically supported by nerve conduction studies and electromyography demonstrating the characteristic nerve damage, along with cerebrospinal fluid analysis showing elevated protein levels. Hospitalization records are also important, particularly if your condition required inpatient care, physical rehabilitation, or respiratory support. Your medical records need to establish a clear timeline from vaccination to symptom onset to diagnosis and treatment. The more precisely that timeline is documented, the stronger your claim.

The On-Table Timeframe

For an on-table GBS claim following a flu shot, the timing of your first symptom relative to your vaccination date is critical. Your records should clearly document when the first symptom or manifestation of GBS appeared. If the onset falls within the three-to-42-day period, the timing requirement may be satisfied, but the condition must also meet the Vaccine Injury Table’s full diagnostic definition to receive the on-Table presumption. If the timing of your first symptom falls outside that window, your attorney will need to evaluate the off-table path and what causation evidence would support it.

Long-Term Care and Compensation

GBS can require extensive acute care and prolonged rehabilitation. Some individuals face ongoing physical therapy, occupational therapy, or management of residual symptoms for years. The VICP does not impose a fixed dollar cap on qualifying medical-expense compensation. A claim may account for reasonable and necessary vaccine-related care that has not been, and will not be, reimbursed from another source, including eligible projected expenses associated with your continued recovery. If your Guillain-Barré Syndrome (GBS) vaccine injury has affected your ability to work, lost earnings and lost earning capacity are also compensable.

The Filing Deadline

You have three years from the date of your first GBS symptom to file a VICP petition. For a condition with the sudden onset that GBS typically has, that date is usually clear, but do not wait. Early legal consultation protects your claim and gives your attorney the time needed to build the strongest possible case.

Why Choose Sadaka Law for Your Guillain-Barré After Flu Shot Vaccine Injury Claim?

A GBS diagnosis is frightening, disorienting, and physically demanding. You need a legal team that brings calm, preparation, and genuine commitment to your case from day one. Here is what that looks like at Sadaka Law.

Calm, Strong Representation When You Need It Most

GBS often strikes suddenly and progresses rapidly. For both the injured individual and their family, the weeks and months that follow can be overwhelming. The last thing you need while managing a serious neurological condition and a long recovery is a legal process that adds to your stress.

We approach every GBS case with a protector mindset: calm, decisive, and focused on what matters most. We handle the legal complexity so you can focus on getting better, communicating clearly and reliably with you and answering your vaccine injury claim questions. And we do not treat your case as a routine file. We treat it as what it is, a serious injury that has changed your life.

More Than 20 Years of VICP Experience Representing 450+ Clients

GBS is one of the most frequently filed vaccine injury conditions in the VICP, and it is one of the conditions our firm knows best. Attorney Mark Sadaka has been handling GBS and other vaccine injury claims for more than 20 years and has represented more than 450 clients through the VICP process.

That depth of experience means we know what these cases require, what documentation matters most, and how to present a GBS claim effectively, whether it proceeds as an on-table matter or requires a more complex off-table approach. We have secured multiple six-figure results on behalf of clients who developed Guillain-Barré after flu shot.

Rigorous Preparation for Every Presentation of GBS

GBS is not a single, uniform condition. It presents differently across its recognized subtypes, progresses differently from person to person, and creates different legal challenges depending on which vaccine is involved and how the diagnostic picture developed.

Some GBS cases are straightforward on-table claims following a flu shot. Others involve atypical presentations, diagnostic evolution from GBS to CIDP, or vaccines for which GBS must be pursued off-table. We build every GBS case with the preparation and attention to detail that any of these scenarios may require, because cutting corners in a neurological vaccine injury claim is not something we are willing to do.

Reach out for Your Free Consultation: Your Guillain-Barré Syndrome (GBS) Vaccine Injury Claim Deserves Immediate Attention

GBS changes lives quickly. The legal process that follows should move just as purposefully. If you developed GBS after receiving a vaccine, contact Sadaka Law today by phone at 201-904-3994 or fill out our online contact form for a free consultation. We will evaluate your situation, confirm whether your claim qualifies as an on-table or off-table matter, and give you a clear picture of your options and next steps, with no obligation and no upfront cost.

Frequently Asked Questions About Guillain-Barré Syndrome (GBS) Vaccine Injury